Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > EV / EBITDA (ltm)

Adverum Biotechnlgs EV / EBITDA (ltm) Chart (ADVM)

Adverum Biotechnlgs annual/quarterly EV / EBITDA (ltm) from 2015 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Adverum Biotechnlgs EV / EBITDA (ltm) for the quarter ending February 02, 2019 was 0.13 a 7.37% increase of 0.01 year over year
  • Adverum Biotechnlgs EV / EBITDA (ltm) for the last 12 months ending February 02, 2019 was 0.13 a 7.37% increase of 0.01 year over year
  • Adverum Biotechnlgs Annual EV / EBITDA (ltm) for 2019 was 0.13 a 29.48% increase of 0.04 from 2018
  • Adverum Biotechnlgs Annual EV / EBITDA (ltm) for 2019 was 0.09 a 10.45% increase of 0.01 from 2018
  • Adverum Biotechnlgs Annual EV / EBITDA (ltm) for 2019 was 0.08 a -46.68% decrease of -0.04 from 2018
Other Valuation Metrics:
  • Adverum Biotechnlgs Market Cap for the quarter ending March 03, 2018 was $361m a 70.28% increase of 253m year over year
  • Adverum Biotechnlgs Price / Book for the quarter ending March 03, 2018 was 1.54 a 65.62% increase of 1.01 year over year
  • Adverum Biotechnlgs Enterprise Value for the quarter ending March 03, 2018 was $170m a 160.05% increase of 273m year over year
View Chart On Koyfin

Quarterly ADVM EV / EBITDA (ltm) Data

02/20190.13
02/20190.09
02/20190.08
02/20190.12
02/20190.20
01/20190.28
01/20190.42
01/20190.42
01/20190.34
01/20190.25

Annual ADVM EV / EBITDA (ltm) Data

20190.13
20190.09
20190.08
20190.12
20190.20
20190.28
20190.42
20190.42
20190.34
20190.25